Evidence map›Paper›PMID 35299096›Full record

ArticleComputerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society2022

Multi-task network for automated analysis of high-resolution endomicroscopy images to detect cervical precancer and cancer.

David Brenes, C J Barberan, Brady Hunt, Sonia G Parra, Mila P Salcedo, Júlio C Possati-Resende, Miriam L Cremer, Philip E Castle, José H T G Fregnani, Mauricio Maza and 3 more

Abstract read
In one paragraph

Article in Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

David BrenesRice University, Houston, TX 77005, USA. Electronic address: drb12@rice.edu.
C J BarberanRice University, Houston, TX 77005, USA. Electronic address: cj.barberan@rice.edu.
Brady HuntRice University, Houston, TX 77005, USA. Electronic address: brady.hunt@dartmouth.edu.
Sonia G ParraRice University, Houston, TX 77005, USA. Electronic address: sonia.parra@hsc.utah.edu.
Mila P SalcedoUniversity of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: mpsalcedo@mdanderson.org.
Júlio C Possati-ResendeBarretos Cancer Hospital, Barretos, São Paulo, Brazil. Electronic address: julio.possati@uol.com.br.
Miriam L CremerCleveland Clinic, Cleveland, OH 44195, USA. Electronic address: mcremer@basichealth.org.
Philip E CastleNational Cancer Institute, Bethesda, MD 20814, USA. Electronic address: philip.castle@nih.gov.
José H T G FregnaniA. C. Camargo Cancer Center, Liberdade, São Paulo, Brazil. Electronic address: mdfregnani@terra.com.br.
Mauricio MazaBasic Health International, San Savlador, El Salvador. Electronic address: mmaza@basichealth.org.
Kathleen M SchmelerUniversity of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: kschmele@mdanderson.org.
Richard BaraniukRice University, Houston, TX 77005, USA. Electronic address: richb@rice.edu.
Rebecca Richards-KortumRice University, Houston, TX 77005, USA. Electronic address: rkortum@rice.edu.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
High Resolution Imaging & HPV Oncoprotein Detection for Global Prevention of Cervical CancerR01CA186132 · NCI · RICE UNIVERSITY · PI RICHARDS-KORTUM, REBECCA R. · 2014 to 2018
$3.1M
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control ProgramsUH3CA189910 · NCI · RICE UNIVERSITY · PI RICHARDS-KORTUM, REBECCA R., SCHMELER, KATHLEEN · 2016 to 2018
$3.0M
Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancerR01CA251911 · NCI · RICE UNIVERSITY · PI RICHARDS-KORTUM, REBECCA R., SCHMELER, KATHLEEN · 2020 to 2024
$2.8M
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control ProgramsUH2CA189910 · NCI · RICE UNIVERSITY · PI RICHARDS-KORTUM, REBECCA R., SCHMELER, KATHLEEN · 2014 to 2015
$1.0M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA186132NCI NIH HHS R01 CA251911NCI NIH HHS UH2 CA189910NCI NIH HHS UH3 CA189910
6 · The paper itself

Abstract

Cervical cancer is a public health emergency in low- and middle-income countries where resource limitations hamper standard-of-care prevention strategies. The high-resolution endomicroscope (HRME) is a low-cost, point-of-care device with which care providers can image the nuclear morphology of cervical lesions. Here, we propose a deep learning framework to diagnose cervical intraepithelial neoplasia grade 2 or more severe from HRME images. The proposed multi-task convolutional neural network uses nuclear segmentation to learn a diagnostically relevant representation. Nuclear segmentation was trained via proxy labels to circumvent the need for expensive, manually annotated nuclear masks. A dataset of images from over 1600 patients was used to train, validate, and test our algorithm; data from 20% of patients were reserved for testing. An external evaluation set with images from 508 patients was used to further validate our findings. The proposed method consistently outperformed other state-of-the art architectures achieving a test per patient area under the receiver operating characteristic curve (AUC-ROC) of 0.87. Performance was comparable to expert colposcopy with a test sensitivity and specificity of 0.94 (p = 0.3) and 0.58 (p = 1.0), respectively. Patients with recurrent human papillomavirus (HPV) infections are at a higher risk of developing cervical cancer. Thus, we sought to incorporate HPV DNA test results as a feature to inform prediction. We found that incorporating patient HPV status improved test specificity to 0.71 at a sensitivity of 0.94.

Indexed as

Papillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsColposcopyEarly Detection of CancerFemaleHumansNeural Networks, ComputerPregnancySensitivity and SpecificityCervical precancerEndomicroscopyMulti-task learningPoint-of-care

Identifiers

PMID35299096
PMCPMC9250128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.